Hantz Financial Services Inc. Boosts Stock Position in Envista Holdings Co. (NYSE:NVST)

Hantz Financial Services Inc. boosted its position in shares of Envista Holdings Co. (NYSE:NVST) by 146.6% in the fourth quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 110,489 shares of the company’s stock after acquiring an additional 65,679 shares during the quarter. Hantz Financial Services Inc.’s holdings in Envista were worth $2,131,000 at the end of the most recent quarter.

Several other institutional investors also recently bought and sold shares of NVST. Mirae Asset Global Investments Co. Ltd. purchased a new position in shares of Envista in the third quarter valued at approximately $31,000. GAMMA Investing LLC boosted its position in Envista by 69.8% in the 3rd quarter. GAMMA Investing LLC now owns 1,766 shares of the company’s stock valued at $35,000 after buying an additional 726 shares during the period. Huntington National Bank grew its stake in shares of Envista by 97.8% in the third quarter. Huntington National Bank now owns 1,919 shares of the company’s stock worth $38,000 after acquiring an additional 949 shares in the last quarter. Blue Trust Inc. increased its position in shares of Envista by 69.7% during the third quarter. Blue Trust Inc. now owns 1,957 shares of the company’s stock worth $39,000 after acquiring an additional 804 shares during the period. Finally, Allspring Global Investments Holdings LLC raised its stake in shares of Envista by 50.8% in the third quarter. Allspring Global Investments Holdings LLC now owns 2,161 shares of the company’s stock valued at $43,000 after acquiring an additional 728 shares in the last quarter.

Wall Street Analyst Weigh In

Several research analysts recently commented on the company. Jefferies Financial Group boosted their target price on Envista from $20.00 to $22.00 and gave the stock a “hold” rating in a research note on Thursday, January 23rd. Needham & Company LLC restated a “hold” rating on shares of Envista in a research note on Thursday, October 31st. Mizuho started coverage on shares of Envista in a report on Wednesday, December 4th. They issued an “underperform” rating and a $20.00 target price on the stock. Stifel Nicolaus boosted their price target on shares of Envista from $18.00 to $21.00 and gave the stock a “buy” rating in a report on Wednesday, October 23rd. Finally, Wells Fargo & Company started coverage on shares of Envista in a report on Tuesday, October 8th. They issued an “equal weight” rating and a $20.00 price objective on the stock. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and three have assigned a buy rating to the company. According to data from MarketBeat, Envista has a consensus rating of “Hold” and an average price target of $20.13.

Envista Stock Performance

NYSE NVST opened at $21.42 on Friday. The company has a fifty day moving average of $20.10 and a two-hundred day moving average of $18.96. The company has a debt-to-equity ratio of 0.42, a current ratio of 2.08 and a quick ratio of 1.77. Envista Holdings Co. has a 1 year low of $15.15 and a 1 year high of $24.79. The company has a market capitalization of $3.69 billion, a PE ratio of -2.76, a P/E/G ratio of 1.88 and a beta of 1.33.

Envista (NYSE:NVST) last released its quarterly earnings results on Wednesday, October 30th. The company reported $0.12 EPS for the quarter, topping the consensus estimate of $0.09 by $0.03. The company had revenue of $601.00 million for the quarter, compared to analyst estimates of $590.34 million. Envista had a positive return on equity of 3.76% and a negative net margin of 53.42%. The firm’s revenue was down 4.8% compared to the same quarter last year. During the same quarter in the previous year, the company posted $0.43 earnings per share. As a group, analysts expect that Envista Holdings Co. will post 0.72 earnings per share for the current year.

About Envista

Envista Holdings Corporation, together with its subsidiaries, develops, manufactures, markets, and sells dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies, and Equipment & Consumables. The Specialty Products & Technologies segment offers dental implant systems, guided surgery systems, biomaterials, and prefabricated and custom-built prosthetics to oral surgeons, prosthodontists and periodontists, and general dentist; and brackets and wires, tubes and bands, archwires, clear aligners, digital orthodontic treatments, retainers, and other orthodontic laboratory products.